Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating Efficacy and Tolerability of Three Times Daily Levetiracetam in Epilepsy Patients

NCT07490769 is registered in ClinicalTrials.gov with Waad Alkathiri as lead sponsor.

NCT NCT07490769
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07490769 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating Efficacy and Tolerability of Three Times Daily Levetiracetam in Epilepsy Patients
Lead sponsor
Waad Alkathiri
Phase
Phase 3
Overall status
Recruiting
Start date
October 1, 2025
Completion date
December 30, 2028
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsy